Total Payments
$141,302
2024 Payments
$33,579
Companies
35
Transactions
489
Medicare Patients
14,217
Medicare Billing
$23.3M
Payment Breakdown by Category
Other$73,586 (52.1%)
Consulting$51,216 (36.2%)
Food & Beverage$9,302 (6.6%)
Travel$6,897 (4.9%)
Education$300.42 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $71,336 | 90 | 50.5% |
| Consulting Fee | $51,216 | 28 | 36.2% |
| Food and Beverage | $9,302 | 341 | 6.6% |
| Travel and Lodging | $6,897 | 24 | 4.9% |
| Honoraria | $2,250 | 1 | 1.6% |
| Education | $300.42 | 5 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $68,438 | 135 | $0 (2024) |
| AUGMENIX, INC. | $33,300 | 27 | $0 (2019) |
| PALETTE LIFE SCIENCES, INC. | $11,981 | 15 | $0 (2023) |
| Teleflex LLC | $11,887 | 10 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $3,246 | 34 | $0 (2024) |
| Photocure Inc | $2,924 | 5 | $0 (2022) |
| AngioDynamics, Inc. | $2,658 | 9 | $0 (2024) |
| IsoRay, Inc | $1,502 | 21 | $0 (2023) |
| Astellas Pharma US Inc | $783.59 | 32 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $740.60 | 35 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $33,579 | 103 | Boston Scientific Corporation ($16,506) |
| 2023 | $29,088 | 105 | Boston Scientific Corporation ($16,207) |
| 2022 | $28,378 | 93 | Boston Scientific Corporation ($23,956) |
| 2021 | $12,511 | 70 | BOSTON SCIENTIFIC CORPORATION ($11,488) |
| 2020 | $1,614 | 16 | Bayer HealthCare Pharmaceuticals Inc. ($1,362) |
| 2019 | $8,079 | 32 | AUGMENIX, INC. ($6,250) |
| 2018 | $19,853 | 31 | Augmenix, Inc. ($19,532) |
| 2017 | $8,200 | 39 | AUGMENIX, INC. ($7,518) |
All Payment Transactions
489 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $12.48 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 12/20/2024 | AngioDynamics, Inc. | NANOKNIFE (Device) | Food and Beverage | In-kind items and services | $3.00 | General |
| Category: OS | ||||||
| 12/19/2024 | Boston Scientific Corporation | SpaceOAR VUE System - 10mL (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $497.00 | General |
| Category: SpaceOAR VUE_URO | ||||||
| 12/19/2024 | Boston Scientific Corporation | SpaceOAR VUE System - 10mL (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $347.90 | General |
| Category: SpaceOAR VUE_URO | ||||||
| 12/13/2024 | Teleflex LLC | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,375.00 | General |
| 12/11/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2024 | BIOPROTECT MEDICAL, INC. | BIOPROTECT BALLOON IMPLANT SYSTEM (Device) | Food and Beverage | In-kind items and services | $149.07 | General |
| Category: Rectal Spacers Used in Prostate Cancer Radiation Therapy | ||||||
| 12/04/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: Diagnostic Imaging | ||||||
| 11/14/2024 | BIOPROTECT MEDICAL, INC. | BIOPROTECT BALLOON IMPLANT SYSTEM (Device) | Food and Beverage | In-kind items and services | $236.78 | General |
| Category: Rectal Spacers Used in Prostate Cancer Radiation Therapy | ||||||
| 11/12/2024 | PFIZER INC. | XTANDI (Drug), TALZENNA | Food and Beverage | In-kind items and services | $26.82 | General |
| Category: ONCOLOGY | ||||||
| 11/07/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $34.86 | General |
| Category: Oncology | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: Oncology | ||||||
| 10/29/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $35.32 | General |
| Category: Oncology | ||||||
| 10/28/2024 | Boston Scientific Corporation | SpaceOAR System (Device) | Food and Beverage | In-kind items and services | $4.94 | General |
| Category: Space OAR_URO | ||||||
| 10/23/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $25.50 | General |
| Category: ONCOLOGY | ||||||
| 10/16/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $32.71 | General |
| Category: Diagnostic Imaging | ||||||
| 10/09/2024 | Teleflex LLC | — | Food and Beverage | In-kind items and services | $6.94 | General |
| 10/08/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $27.51 | General |
| Category: Oncology | ||||||
| 10/03/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $9.31 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 10/02/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $22.93 | General |
| Category: Oncology | ||||||
| 10/01/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $0.65 | General |
| Category: Oncology | ||||||
| 09/25/2024 | AngioDynamics, Inc. | NANOKNIFE (Device) | Food and Beverage | In-kind items and services | $105.01 | General |
| Category: OS | ||||||
| 09/24/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $5.37 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 09/19/2024 | Boston Scientific Corporation | SpaceOAR VUE System - 10mL (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,491.00 | General |
| Category: SpaceOAR VUE_URO | ||||||
| 09/19/2024 | Boston Scientific Corporation | SpaceOAR VUE System - 10mL (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,491.00 | General |
| Category: SpaceOAR VUE_URO | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 39 | 3,917 | 21,957 | $24.1M | $5.9M |
| 2022 | 41 | 3,655 | 20,867 | $23.9M | $6.2M |
| 2021 | 38 | 3,175 | 19,541 | $21.3M | $5.4M |
| 2020 | 38 | 3,470 | 21,228 | $23.6M | $5.8M |
Total Patients
14,217
Total Services
83,593
Medicare Billing
$23.3M
Procedure Codes
156
All Medicare Procedures & Services
156 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| Q2043 | Sipuleucel-t, minimum of 50 million autologous cd54+ cells activated with pap-gm-csf, including leukapheresis and all other preparatory procedures, per infusion | Office | 2023 | 18 | 53 | $5.2M | $2.2M | 42.8% |
| G6015 | Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | Office | 2023 | 182 | 5,816 | $9.8M | $1.7M | 17.8% |
| 55874 | Injection of biodegradable material next to prostate | Office | 2023 | 140 | 140 | $1.3M | $337,009 | 26.7% |
| 77301 | High precision radiation therapy planning | Office | 2023 | 159 | 159 | $1.1M | $244,620 | 21.6% |
| 77427 | Radiation treatment management, 5 treatment sessions | Office | 2023 | 180 | 1,174 | $704,400 | $191,437 | 27.2% |
| A4648 | Tissue marker, implantable, any type, each | Office | 2023 | 153 | 705 | $564,000 | $152,684 | 27.1% |
| 77373 | Cranial lesion surgery using radiation over multiple sessions | Office | 2023 | 30 | 172 | $567,600 | $145,364 | 25.6% |
| 77300 | Calculation of radiation therapy dose | Office | 2023 | 166 | 2,289 | $686,700 | $126,829 | 18.5% |
| 77338 | Design and construction of radiation treatment device for high precision radiation therapy | Office | 2023 | 190 | 293 | $445,360 | $114,209 | 25.6% |
| 77336 | Continuing radiation therapy consultation per week | Office | 2023 | 200 | 1,226 | $275,850 | $90,711 | 32.9% |
| G6017 | Intra-fraction localization and tracking of target or patient motion during delivery of radiation therapy (eg,3d positional tracking, gating, 3d surface tracking), each fraction of treatment | Office | 2023 | 164 | 5,013 | $1.0M | $89,231 | 8.9% |
| 77290 | Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | Office | 2023 | 197 | 234 | $500,760 | $80,349 | 16.0% |
| 77280 | Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | Office | 2023 | 190 | 301 | $183,610 | $67,948 | 37.0% |
| G6002 | Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | Office | 2023 | 84 | 789 | $299,820 | $49,565 | 16.5% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 43 | 276 | $508,000 | $37,224 | 7.3% |
| 77263 | Complex radiation therapy planning | Office | 2023 | 185 | 204 | $144,840 | $28,738 | 19.8% |
| 77318 | Complex radiation therapy planning for delivery of internal radiation | Office | 2023 | 32 | 78 | $95,940 | $28,682 | 29.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 158 | 158 | $47,814 | $21,655 | 45.3% |
| 77435 | Management of cranial lesion surgery using radiation over multiple sessions | Office | 2023 | 28 | 37 | $77,700 | $20,289 | 26.1% |
| 77334 | Design and construction of complex radiation treatment device | Office | 2023 | 148 | 165 | $87,450 | $17,201 | 19.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 94 | 94 | $37,600 | $16,926 | 45.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 129 | 203 | $33,089 | $13,755 | 41.6% |
| 77295 | 3d radiation therapy planning | Office | 2023 | 32 | 32 | $76,800 | $12,891 | 16.8% |
| 55876 | Placement of device in prostate for radiation therapy | Office | 2023 | 153 | 153 | $100,980 | $10,952 | 10.8% |
| 77307 | Complex radiation therapy planning for delivery of external radiation | Office | 2023 | 30 | 39 | $35,100 | $9,390 | 26.8% |
About Dr. Parthiv Mehta, M.D
Dr. Parthiv Mehta, M.D is a Radiation Oncology healthcare provider based in Glenview, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/27/2007. The National Provider Identifier (NPI) number assigned to this provider is 1962539759.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Parthiv Mehta, M.D has received a total of $141,302 in payments from pharmaceutical and medical device companies, with $33,579 received in 2024. These payments were reported across 489 transactions from 35 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($71,336).
As a Medicare-enrolled provider, Mehta has provided services to 14,217 Medicare beneficiaries, totaling 83,593 services with total Medicare billing of $23.3M. Data is available for 4 years (2020–2023), covering 156 distinct procedure/service records.
Ad
Practice Information
- Specialty Radiation Oncology
- Location Glenview, IL
- Active Since 02/27/2007
- Last Updated 07/12/2019
- Taxonomy Code 2085R0001X
- Entity Type Individual
- NPI Number 1962539759
Products in Payments
- SpaceOAR VUE System - 10mL (Device) $56,085
- SpaceOAR (Device) $33,300
- SPACEOAR VUE (Device) $10,889
- CYSVIEW (Drug) $2,924
- NANOKNIFE (Device) $2,658
- Nubeqa (Drug) $1,692
- Xofigo (Drug) $1,554
- Brachytherapy Source (Device) $1,404
- PROVENGE (Drug) $915.52
- General - Therapies (Device) $756.03
- ORGOVYX (Drug) $724.26
- ERLEADA (Drug) $547.61
- XTANDI (Drug) $489.04
- Xtandi (Drug) $386.73
- BIOPROTECT BALLOON IMPLANT SYSTEM (Device) $385.85
- SpaceOAR System (Device) $368.77
- Axumin (Drug) $241.83
- GENERAL THERAPIES (Device) $239.79
- POSLUMA (Drug) $217.64
- ELIGARD (Drug) $196.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.